MANILA, Philippines – Clinical trials of the Japanese antiviral drug Avigan in COVID-19 patients in the Philippines will begin on Monday, according to the Ministry of Health (DOH).
“Maguumpisa tayo ngayon then after nine months magsubmit ng turns out,” Vergeire told reporters on an online media forum (we’ll start and after nine months we’ll send the result).
He has earmarked at least 18 million pesos for Avigan’s trials.
Avigan would have tested positive for patients with COVID-19 in China, i.e. those with mild symptoms.[Ac]
The Inquirer Foundation supports our leaders in the fitness sector and still accepts donations of money to be deposited into the Golden Bank Current Account (BDO) – 007960018860 or to make a donation through PayMaya this link.
We use cookies for the most productive enjoyment on our website.By continuing, you are satisfied with our use of cookies. For more information, click this link.